Treatment of refractory myositis: A randomized crossover study of two new cytotoxic regimensLourdes Villalba, Frederick W. Miller, Suzanne H. Burgess et al.|Arthritis & Rheumatism|1998Cited by 176
Treatment of refractory myositis: A randomized crossover study of two new cytotoxic regimensLourdes Villalba, Frederick W. Miller, Mark F. Gourley et al.|Arthritis & Rheumatism|1998Cited by 123
Common mutations in the phosphofructokinase-M gene in Ashkenazi Jewish patients with glycogenesis VII--and their population frequency.Jeffrey B. Sherman, Paul H. Plötz, Nina Raben et al.|PubMed|1994Cited by 66
Functional expression of human mutant phosphofructokinase in yeast: genetic defects in French Canadian and Swiss patients with phosphofructokinase deficiency.Nina Raben, Jürgen J. Heinisch, R Exelbert et al.|PubMed|1995Cited by 60
A 5' splice junction mutation leading to exon deletion in an Ashkenazic Jewish family with phosphofructokinase deficiency (Tarui disease).Nina Raben, Paul H. Plötz, Jeffrey B. Sherman et al.|Journal of Biological Chemistry|1993Cited by 56